of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system" [3] . The award consists of a prize of € 3000 for the Outstanding award-winning research article, published in the October 2013 issue, Dr Rudolf Jaenisch and his colleagues utilized a modified version of the CRISPR/Cas9 system, a newly emerging genetic tool, to create RNA-guided transcriptional activators that could act to robustly activate endogenous target gene expression in vivo, thus providing a versatile system to specifically manipulate gene expression at both the cellular and organism levels.
Please join us to congratulate Drs Daley, Morris, Han, and Jaenisch on their winning of the 2013 Sanofi-Cell Research Outstanding Paper Award. We have no doubt that this yearly award program, along with the rapidly rising status of the journal, will encourage more and more scientists to submit their best work to Cell Research. The award-winning review by Drs Daley and Morris was published in the January issue of 2013. The review provides an expert analysis on the current strategies to manipulate cell identities and discuss challenges faced by the field in its marching towards the ultimate goal of harnessing the technology of cell fate conversion for the production of medically relevant cell populations. In the first award-winning research article, published in the August 2013 issue, Dr Jiahuai Han and his colleagues report the detailed characterization of Mlkl knockout mice, providing definitive in vivo genetic evidence for the critical role of Mlkl in mediating programmed necrosis, a form of cell death that is distinct from apoptosis. In the second
Dangsheng Li

